IL18 and cholangiocarcinoma: Since IL-2/IL-18-induced NK cells kill CCA cells and express antigen-presenting cell-associated markers, they could act as antigen-presenting cells, exposing CCA-derived antigens to both CD4+ and CD8+ T cells and acting as a bridge between innate and adaptive immunity.